Market Need Target market has a large base of procedures requiring airway management during sedation or anesthesia, presenting a sizable opportunity for a hands-free airway solution like JED to improve safety and efficiency.

Strategic Advantage Hypnoz positions JED as a standard of care alternative for non-endotracheal or non-LMA cases, indicating potential to disrupt current airway management practices and drive adoption among anesthesia providers seeking safer, hands-free options.

Growth Potential Revenue is currently under 1 million with a very small team, suggesting an opportunity for channel sales, partnerships with distributors, and ventures to expand sales in hospital networks and ambulatory surgery centers.

Competitive Landscape Direct competitors include large, established players in respiratory and anesthesia devices; differentiating by safety, ease of use, and integration with existing anesthesia workflows could unlock partner and hospital procurement opportunities.

Engagement Levers Evidence of founder-driven innovation and a tangible product (JED) with clear clinical benefits provides material for clinical education, demonstrations, and pilot programs to drive trialing and early adoption.